[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NO2016022I2 - Olodaterol hydroklorid og tiotropium bromidmonohydrat - Google Patents

Olodaterol hydroklorid og tiotropium bromidmonohydrat

Info

Publication number
NO2016022I2
NO2016022I2 NO2016022C NO2016022C NO2016022I2 NO 2016022 I2 NO2016022 I2 NO 2016022I2 NO 2016022 C NO2016022 C NO 2016022C NO 2016022 C NO2016022 C NO 2016022C NO 2016022 I2 NO2016022 I2 NO 2016022I2
Authority
NO
Norway
Prior art keywords
tiotropium bromide
bromide monohydrate
olodaterol hydrochloride
olodaterol
hydrochloride
Prior art date
Application number
NO2016022C
Other languages
English (en)
Other versions
NO2016022I1 (no
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34966478&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO2016022(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE102004019540A external-priority patent/DE102004019540A1/de
Priority claimed from DE102004052987A external-priority patent/DE102004052987A1/de
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of NO2016022I2 publication Critical patent/NO2016022I2/no
Publication of NO2016022I1 publication Critical patent/NO2016022I1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Rheumatology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO2016022C 2004-04-22 2016-12-01 Olodaterol (som hydroklorid)-(6-hydroksy-8-{1-hydroksy-2-[2-(4-metoksy-fenyl)-1,1-dimetyl-etylamino]-etyl}-4H-benzo[1,4]oksazin-3-on) og tiotropium (som bromidmonohydrat) NO2016022I1 (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE102004019540A DE102004019540A1 (de) 2004-04-22 2004-04-22 Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen
DE102004052987A DE102004052987A1 (de) 2004-11-03 2004-11-03 Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen
EP05002496 2005-02-07
PCT/EP2005/004073 WO2005102349A1 (de) 2004-04-22 2005-04-18 Arzneinmittelkombinationen enthaltend benzoxazine zur behandlung von atemwegserkrankungen

Publications (2)

Publication Number Publication Date
NO2016022I2 true NO2016022I2 (no) 2016-12-01
NO2016022I1 NO2016022I1 (no) 2016-12-01

Family

ID=34966478

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20065060A NO337714B1 (no) 2004-04-22 2006-11-02 Medikamentkombinasjoner inneholdende benzoksaziner og anvendelse av slike til behandling av respiratoriske forstyrrelser
NO2016022C NO2016022I1 (no) 2004-04-22 2016-12-01 Olodaterol (som hydroklorid)-(6-hydroksy-8-{1-hydroksy-2-[2-(4-metoksy-fenyl)-1,1-dimetyl-etylamino]-etyl}-4H-benzo[1,4]oksazin-3-on) og tiotropium (som bromidmonohydrat)

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO20065060A NO337714B1 (no) 2004-04-22 2006-11-02 Medikamentkombinasjoner inneholdende benzoksaziner og anvendelse av slike til behandling av respiratoriske forstyrrelser

Country Status (32)

Country Link
EP (2) EP2422786B1 (no)
JP (1) JP2007533683A (no)
KR (2) KR20130049840A (no)
AR (1) AR049262A1 (no)
AT (1) ATE539754T1 (no)
AU (1) AU2005235419B2 (no)
BE (1) BE2015C065I2 (no)
BR (1) BRPI0510080B8 (no)
CA (1) CA2559699C (no)
CY (3) CY1113890T1 (no)
DK (2) DK1781298T3 (no)
EA (1) EA013157B1 (no)
EC (1) ECSP066947A (no)
ES (2) ES2523518T3 (no)
FI (1) FIC20170005I1 (no)
HU (1) HUS1500058I1 (no)
IL (2) IL177685A (no)
LT (1) LTC1781298I2 (no)
LU (1) LU93066I2 (no)
MY (1) MY148945A (no)
NL (1) NL300779I2 (no)
NO (2) NO337714B1 (no)
NZ (1) NZ550797A (no)
PE (1) PE20060462A1 (no)
PL (2) PL1781298T4 (no)
PT (2) PT1781298E (no)
SG (1) SG152237A1 (no)
SI (2) SI1781298T1 (no)
TW (2) TWI374739B (no)
UY (1) UY28861A1 (no)
WO (1) WO2005102349A1 (no)
ZA (1) ZA200606624B (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7056916B2 (en) 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
DE102004024452A1 (de) * 2004-05-14 2005-12-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation von Betaagonisten
US7220742B2 (en) 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
US7923455B2 (en) * 2005-01-28 2011-04-12 Boehringer Ingelheim International Gmbh Medicaments for the prevention or treatment of heart failure comprising administration of an anticholinergic
JP2008530177A (ja) * 2005-02-16 2008-08-07 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 抗コリン作用薬及びエチプレドノールを含有する医薬組成物
BRPI0614410A2 (pt) 2005-08-15 2011-03-29 Boehringer Ingelheim Int processo para preparação de betamiméticos
TWI396541B (zh) * 2005-10-10 2013-05-21 Boehringer Ingelheim Int 用於治療呼吸疾病之新穎藥物組合
TWI389692B (zh) * 2005-10-10 2013-03-21 Boehringer Ingelheim Int 用以吸入β-共效劑的氣溶膠調配物
ATE529399T1 (de) 2005-11-10 2011-11-15 Nicholas S Bodor Sanfte anticholinerge ester
WO2007093608A1 (de) * 2006-02-16 2007-08-23 Boehringer Ingelheim International Gmbh Arzneimittelkombinationen zur behandlung von atemwegserkrankungen
ATE505193T1 (de) * 2006-08-07 2011-04-15 Boehringer Ingelheim Int Arzneimittelkombinationen zur behandlung von atemwegserkrankungen
UY30543A1 (es) * 2006-08-18 2008-03-31 Boehringer Ingelheim Int Formulacion de aerosol para la inhalacion de beta- agonistas
UY30542A1 (es) * 2006-08-18 2008-03-31 Boehringer Ingelheim Int Formulacion de aerosol para la inhalacion de agonistas beta
EP2086641A2 (en) * 2006-10-26 2009-08-12 Boehringer Ingelheim International GmbH Egfr kinase inhibitor combinations for the treatment of respiratory and gastrointestinal disorders
EP1921070A1 (de) 2006-11-10 2008-05-14 Boehringer Ingelheim Pharma GmbH & Co. KG Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstelllung
BRPI0907916A2 (pt) 2008-02-07 2015-07-28 Boehringer Ingelheim Int Heterociclos espirociclos, medicamentos contendo esses compostos, e processos para preparar os mesmos
CA2733153C (en) 2008-08-08 2016-11-08 Boehringer Ingelheim International Gmbh Cyclohexyloxy substituted heterocycles, pharmaceutical compositions containing these compounds and processes for preparing them
EP2370053A1 (de) * 2008-11-27 2011-10-05 Boehringer Ingelheim International GmbH Neue pulverförmige kristalline arzneimittel zur inhalation
WO2014016548A2 (en) * 2012-07-27 2014-01-30 Cipla Limited Pharmaceutical composition
EP2906218B1 (en) 2012-10-09 2016-12-14 Boehringer Ingelheim International GmbH Beta-2-adrenoceptor agonist for the treatment of cough

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4460581A (en) * 1982-10-12 1984-07-17 Boehringer Ingelheim Kg (1-Hydroxy-2-amino-alkyl)-substituted benzoxazinones and benzoxazolinones
US4570630A (en) 1983-08-03 1986-02-18 Miles Laboratories, Inc. Medicament inhalation device
IE59026B1 (en) 1985-07-30 1993-12-15 Glaxo Group Ltd Devices for administering medicaments to patients
SE453566B (sv) 1986-03-07 1988-02-15 Draco Ab Anordning vid pulverinhalatorer
SG45171A1 (en) 1990-03-21 1998-01-16 Boehringer Ingelheim Int Atomising devices and methods
DE4318455A1 (de) 1993-06-03 1994-12-08 Boehringer Ingelheim Kg Kapselhalterung
DE19536902A1 (de) 1995-10-04 1997-04-10 Boehringer Ingelheim Int Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung
CZ20023537A3 (cs) 2000-04-27 2003-02-12 Boehringer Ingelheim Pharma Kg Betamimetika, způsob jejich výroby a použití jako farmaceutický prostředek
EP1326862B1 (de) 2000-10-12 2004-09-15 BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG Kristallines monohydrat von tiotropiumbromid, verfahren zu dessen herstellung und dessen verwendung zur herstellung eines arzneimittels
IL159238A0 (en) 2001-06-22 2004-06-01 Boehringer Ingelheim Pharma Crystalline anticholinergic, method for its production, and use thereof in the production of a drug
DE10130371A1 (de) * 2001-06-23 2003-01-02 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika, Corticosteroiden und Betamimetika
ES2203327B1 (es) * 2002-06-21 2005-06-16 Almirall Prodesfarma, S.A. Nuevos carbamatos de quinuclidina y composiciones farmaceuticas que los contienen.
DE10230751A1 (de) * 2002-07-09 2004-01-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittelkompositionen auf der Basis neuer Anticholinergika und EGFR-Kinase-Hemmern
DE10246374A1 (de) * 2002-10-04 2004-04-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Betamimetika mit verlängerter Wirkungsdauer, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
DE10253282A1 (de) * 2002-11-15 2004-05-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittel zur Behandlung von chronisch obstruktiver Lungenerkrankung

Also Published As

Publication number Publication date
ES2523518T3 (es) 2014-11-26
TW201231055A (en) 2012-08-01
DK2422786T3 (da) 2014-11-17
ES2380370T3 (es) 2012-05-11
EA013157B1 (ru) 2010-02-26
BRPI0510080B1 (pt) 2020-08-18
HUS1500058I1 (hu) 2016-01-28
BE2015C065I2 (no) 2024-08-08
ZA200606624B (en) 2008-01-08
PL1781298T3 (pl) 2012-06-29
WO2005102349A1 (de) 2005-11-03
SI1781298T1 (sl) 2012-04-30
NO337714B1 (no) 2016-06-06
KR20130049840A (ko) 2013-05-14
ATE539754T1 (de) 2012-01-15
EA200601846A1 (ru) 2007-04-27
EP2422786B1 (de) 2014-08-13
NO20065060L (no) 2006-11-21
CY1115719T1 (el) 2017-01-25
TWI374739B (en) 2012-10-21
BRPI0510080A (pt) 2007-10-16
MY148945A (en) 2013-06-14
FIC20170005I1 (fi) 2017-01-13
KR20070015592A (ko) 2007-02-05
LU93066I2 (fr) 2016-07-11
NL300779I2 (nl) 2017-11-02
CA2559699C (en) 2012-06-19
LTC1781298I2 (lt) 2018-09-25
AU2005235419A1 (en) 2005-11-03
IL177685A (en) 2013-10-31
NO2016022I1 (no) 2016-12-01
CA2559699A1 (en) 2005-11-03
SG152237A1 (en) 2009-05-29
NZ550797A (en) 2010-08-27
IL226562A0 (en) 2013-06-27
PT1781298E (pt) 2012-02-03
PL2422786T3 (pl) 2015-02-27
ECSP066947A (es) 2007-01-26
TWI372056B (en) 2012-09-11
CY2017014I2 (el) 2017-11-14
IL177685A0 (en) 2006-12-31
EP2422786A1 (de) 2012-02-29
EP1781298A1 (de) 2007-05-09
SI2422786T1 (sl) 2014-12-31
JP2007533683A (ja) 2007-11-22
DK1781298T3 (da) 2012-05-07
CY1113890T1 (el) 2016-07-27
PL1781298T4 (pl) 2017-07-31
UY28861A1 (es) 2005-11-30
PT2422786E (pt) 2014-11-12
AU2005235419B2 (en) 2010-11-04
AR049262A1 (es) 2006-07-12
BRPI0510080B8 (pt) 2021-05-25
PE20060462A1 (es) 2006-06-19
KR101287460B1 (ko) 2013-07-23
EP1781298B1 (de) 2012-01-04
CY2017014I1 (el) 2017-11-14

Similar Documents

Publication Publication Date Title
NO2016022I2 (no) Olodaterol hydroklorid og tiotropium bromidmonohydrat
NO2017017I1 (no) umeklinidium og vilanterol
FIC20210017I1 (fi) Kabotegraviiri tai sen farmaseuttisesti hyväksyttävä suola tai solvaatti
NO2022022I1 (no) Fedratinib, or a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable hydrate thereof, in particular fedratinib dihydrochloride monohydrate
NO2017051I1 (no) Kariprazin, eventuelt i form av et salt, inkludert kariprazin hydroklorid
NO20072713L (no) Forbindelse omfattende ecteinascidin og et disakkarid
NO2015008I2 (no) olaparib og salter derav
NO20081604L (no) Nitrogeninneholdende heterocyklisk forbindelse og farmasøytisk anvendelse derav
DK2305250T3 (da) Benzimidazolderivater og anvendelse heraf som proteinkinaseinhibitorer
DK1928457T3 (da) Quinoliner og deres terapeutiske anvendelse
DK2727583T3 (da) Lægemiddelbærer og lægemiddelbærerkit til at inhibere fibrose
DK1592686T3 (da) Gyrase-inhibitorer og anvendelser deraf
MA29039B1 (fr) Dibenzylamines et derives
IL181849A0 (en) Halogenated benzamide derivatives
DK1856051T3 (da) Amorft lercanidipinhydrochlorid
ATE412651T1 (de) Pyrrolopyridinderivate
ATE500227T1 (de) Amidderivate
DK1771421T3 (da) N-hydroxyamidderivater og anvendelse deraf
FI20041057A0 (fi) Pelkistysainekoostumus
DK1709018T3 (da) Acylaminothiazolderivater og anvendelse deraf som beta-amyloid-hæmmere
DK1594859T3 (da) Indazolamider med analgetisk aktivitet
DK1622892T3 (da) Indazoler med analgetisk aktivitet
DK1812072T3 (da) Benzothiazol-præparat og anvendelse deraf
DE602005014339D1 (de) Ür
DK2298415T3 (da) Tiotropiumbromid-mikronisat